Artelo Biosciences (Artelo Biosciences) Total Assets : $10.35 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Artelo Biosciences Total Assets?

Artelo Biosciences's Total Assets for the quarter that ended in Mar. 2024 was $10.35 Mil.

During the past 12 months, Artelo Biosciences's average Total Assets Growth Rate was -8.30% per year. During the past 3 years, the average Total Assets Growth Rate was 5.40% per year. During the past 5 years, the average Total Assets Growth Rate was 77.30% per year.

During the past 10 years, Artelo Biosciences's highest 3-Year average Total Assets Growth Rate was 1207.30%. The lowest was 5.40%. And the median was 130.95%.

Total Assets is connected with ROA %. Artelo Biosciences's annualized ROA % for the quarter that ended in Mar. 2024 was -84.90%. Total Assets is also linked to Revenue through Asset Turnover. Artelo Biosciences's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

Artelo Biosciences Total Assets Historical Data

The historical data trend for Artelo Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artelo Biosciences Total Assets Chart

Artelo Biosciences Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

6.48

4.38

12.64

20.42

13.04

Artelo Biosciences Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															18.48	16.88	15.50	13.04	10.35

Artelo Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Artelo Biosciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	11.752	+	1.291
	=	13.04

Artelo Biosciences's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	9.537	+	0.817
	=	10.35

Artelo Biosciences (NAS:ARTLW) Total Assets Explanation

Total Assets is connected with ROA %.

Artelo Biosciences's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-9.932	/	( (13.043	+	10.354)	/ 2 )
	=	-9.932	/	11.6985
	=	-84.90 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Artelo Biosciences's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0	/	( (13.043	+	10.354)	/ 2 )
=	0	/	11.6985
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Artelo Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Artelo Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Artelo Biosciences (Artelo Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artelo Biosciences Inc (NAS:ARTLW) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ARTL:USA

Address

505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075

Website

https://www.artelobio.com

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing and commercializing treatments that control endocannabinoid system. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.